Literature DB >> 35792552

Evaluation of the Randox and Fuji Dri-Chem vcCRP-P assays of canine C-reactive protein.

Sung-Ah An1, Ye-In Oh2, Ul-Soo Choi3, Jong-Bok Lee4, Kyoung-Won Seo2.   

Abstract

In veterinary medicine, measurement of canine C-reactive protein (cCRP) is used widely to detect inflammatory diseases. We evaluated the precision of Randox and Fuji assays for cCRP, as well as accuracy, correlation, and agreement compared to a reference ELISA. Blood samples from 71 client-owned dogs (20 healthy, 51 diseased) were analyzed with the 3 assays. Inter-assay CVs were ~3.5% with both the Randox and Fuji assays. The mean biases were -1.90% for the Randox and -5.93% for the Fuji test; the targeted biases were ~8.5% for both assays. The CV, bias, and observed total error were acceptable for the 2 assays compared to ASVCP recommendations based on biological variation studies. The Spearman correlation coefficient for cCRP concentration compared with the reference ELISA was 0.83 for the Randox test and 0.92 for the Fuji test. Both assays measured cCRP precisely at intermediate and increased concentrations. Correlation with the reference ELISA was good, and both assays could be used to evaluate cCRP concentrations in veterinary practice. However, the assays did not reach analytical agreement; hence the results obtained by these assays are not interchangeable, and serial monitoring of cCRP requires the use of the same assay.

Entities:  

Keywords:  C-reactive protein; dogs; inflammation; point-of-care testing

Mesh:

Substances:

Year:  2022        PMID: 35792552      PMCID: PMC9446305          DOI: 10.1177/10406387221108450

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.569


  16 in total

1.  ASVCP guidelines: allowable total error guidelines for biochemistry.

Authors:  Kendal E Harr; Bente Flatland; Mary Nabity; Kathleen P Freeman
Journal:  Vet Clin Pathol       Date:  2013-12       Impact factor: 1.180

2.  Evaluation of three automated human immunoturbidimetric assays for the detection of C-reactive protein in dogs.

Authors:  Stefanie Klenner; Natali Bauer; Andreas Moritz
Journal:  J Vet Diagn Invest       Date:  2010-07       Impact factor: 1.279

3.  Comparing methods of measurement: why plotting difference against standard method is misleading.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

4.  Evaluation of a point-of-care test for canine C-reactive protein.

Authors:  Hanna D Plickert; Ralf Einspanier; Gisela Arndt; Leo Brunnberg; Barbara Kohn
Journal:  Vet Clin Pathol       Date:  2011-08-09       Impact factor: 1.180

5.  C-reactive protein concentrations in serum of dogs with naturally occurring renal disease.

Authors:  Jens Raila; Florian J Schweigert; Barbara Kohn
Journal:  J Vet Diagn Invest       Date:  2011-06-15       Impact factor: 1.279

6.  Changes in C-reactive protein and haptoglobin in dogs with lymphatic neoplasia.

Authors:  R Mischke; M Waterston; P D Eckersall
Journal:  Vet J       Date:  2006-08-09       Impact factor: 2.688

7.  Evaluation of a commercially available human C-reactive protein (CRP) turbidometric immunoassay for determination of canine serum CRP concentration.

Authors:  Mads Kjelgaard-Hansen; Asger Lundorff Jensen; Annemarie T Kristensen
Journal:  Vet Clin Pathol       Date:  2003       Impact factor: 1.180

8.  Evaluation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of C-reactive protein in canine serum.

Authors:  M Kjelgaard-Hansen; A T Kristensen; A L Jensen
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2003-04

9.  C-reactive protein concentration in dogs with various diseases.

Authors:  Masaaki Nakamura; Masashi Takahashi; Koichi Ohno; Akiko Koshino; Ko Nakashima; Asuka Setoguchi; Yasuhito Fujino; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2008-02       Impact factor: 1.267

10.  Use of heterologous immunoassays for quantification of serum proteins: The case of canine C-reactive protein.

Authors:  Alberto Muñoz-Prieto; Asta Tvarijonaviciute; Damián Escribano; Silvia Martínez-Subiela; José J Cerón
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.